Adjuvant radiotherapy for low-risk early breast cancer in elderly women: evidence from randomized trials

por Burgos-Burgos, Javier, Pinar-Sedeño, Beatriz, García-Cabrera, Laura, Rodríguez-Ibarria, Nieves, Cabezón-Pons, Auxiliadora, Lloret-Sáenz-Bravo, Marta, Vicente-Rubio, Elena, Vega-Benítez, Víctor, Travieso-Aja, María, Lara, Pedro C.
Publicado 2020

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

por Salvador Bofill, Javier, Moreno Anton, Fernando, Rodriguez Sanchez, Cesar Augusto, Galve Calvo, Elena, Hernando Melia, Cristina, Ciruelos Gil, Eva Maria, Vidal, Maria, Jiménez-Rodriguez, Begoña, De la Cruz Merino, Luis, Martínez Jañez, Noelia, Villanueva Vazquez, Rafael, de Toro Salas, Ruben, Anton Torres, Antonio, Alvarez Lopez, Isabel Manuela, Gavila Gregori, Joaquin, Quiroga Garcia, Vanesa, Vicente Rubio, Elena, De la Haba-Rodriguez, Juan, Gonzalez-Santiago, Santiago, Diaz Fernandez, Nieves, Barnadas Molins, Agusti, Cantos Sanchez de Ibargüen, Blanca, Delgado Mingorance, Juan Ignacio, Bellet Ezquerra, Meritxell, de Casa, Sonia, Gimeno, Asuncion, Martin, Miguel
Publicado 2022